The past 12 months have been a wild ride for both investors and cannabis shareholders, as evidenced by big rallies as well as steep declines.
Cannabis stocks substantially fell over the last year, with the U.S. Marijuana Index plunging 70% in 2022, according to BNN Bloomberg. Analysts and market experts blame the negative trend on the lack of policy change at the federal level and weakness in the equity markets.
Although, investors who decided to buy shares of the five marijuana operators below are, if not pleased, then at least not disappointed with their returns.
Top Marijuana Performers Over The Past 12 Months
To come up with the list of top performers, we took into consideration cannabis stocks recommended by top sector analysts such as Cantor Fitzgerald's Pablo Zuanic and Owen Bennett of Jefferies and the brands that had the smallest declines in total return over past years.
You can meet experts like Pablo Zuanic and the top cannabis executives from the list below at the most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference.
Returning to Miami for its 16th edition, this is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don't miss out. Secure your tickets now before prices go up.
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- 12-Month Trailing Return (in percentages): -44.9
- Price Action: The company's shares traded 2.35% lower at $0.7313 per share at the time of writing on Tuesday.
- Market Cap: $232.22 million
Touted earlier as one of Canada's best operators, the company reported a 43% increase in the first quarter net revenue in January to CA$43.3 million ($32.3 million) compared to CA$30.4 million in the same period of fiscal 2022. Net income was CA$5.3 million, compared to a net loss of …